SYDNEY, Australia, Sept. 12 /PRNewswire/ -- The clinical results of the VentrAssist left ventricular assist device (LVAD) CE Mark Bridge-to-Transplant Trial were presented at the European Association of Cardiothoracic Surgeons (EACTS) in Sweden this week.
